skip to Main Content
Get your free newsletter: Actionable insight each morning for self-directed investors. 

The AIM index had an uninspiring session, flitting in and out of positive territory before closing a shade lower at 944.18

  • Valirx up 40%
  • Integumen up 25%
  • Ncondezi down 20%
  • Grafenia down 17%

Valirx [LON:VAL] was the day’s biggest riser, adding 40% despite any formal news announcement. Chat suggests there’s anticipation building over the release of results regarding one of its cancer drug trials.

Integumen [LON:SKIN] was another stock in favour today, rising 25% to push past those previous highs set in August. There’s again nothing concrete out here but with the AGM set for Thursday and an RNS update expected ahead of that, hopes are clearly running high.

Ncondezi [LON:NCCL] was the day’s biggest faller, off 20% after confirming General Electric’s decision to exit the new build coal power market. This raises questions over GE’s involvement in Ncondezi’s power plant and mine operation in Mozambique. Any clarity over how this will progress will be closely watched for.

Grafenia [LON:GRA] had a bruising day, off 17% following a trading update this morning. Sales have been impacted by COVID, with August revenues down around 30% from last year. There’s also concern that the post-summer rally won’t materialise this year, with September sales likely to be little better. However trade was limited today – it was just all weighted on the sell side.

Become a better investor with SharePad Designed to give you the confidence to pick your own investments, Sharepad gives you access to a wealth of information on UK, US & European stocks. Find out more

Please note this article does not constitute investment advice. Investors are encouraged to do their own research beforehand or consult a professional advisor.

Tony Cross

Tony Cross

Tony Cross is a market commentator with over 15 years of experience, producing compelling, insightful copy for journalists and investors alike. Focusing on macroeconomics, UK blue chip equities and inter market analysis, Cross's commentary is well regarded for its clarity and ability to cut through the waffle. He has been quoted in publications as diverse as The Financial Times, The Times, The Guardian and The Sun. He has also been a regular guest on both Share Radio and TipTV.

Stocks in Focus

Here are some of the smaller companies we are following most closely. They all represent significant growth stories in our view. Our in-depth reports go into more detail on why we like them.


Get your free daily newsletter: 

Thanks to our Partners

Our partners are established, regulated businesses and we are grateful for their support.

FP Markets
Trade Nation
Back To Top